|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Saif MW: Controversies in the adjuvant
treatment of pancreatic adenocarcinoma. JOP. 8:545–552.
2007.PubMed/NCBI
|
|
3
|
Saif MW: Pancreatic neoplasm in 2011: An
update. JOP. 12:316–321. 2011.PubMed/NCBI
|
|
4
|
Balkwill F and Coussens LM: Cancer: An
inflammatory link. Nature. 431:405–406. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Greten FR and Karin M: The IKK/NF-kappaB
activation pathway-a target for prevention and treatment of cancer.
Cancer Lett. 206:193–199. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pikarsky E, Porat RM, Stein I, Abramovitch
R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E and
Ben-Neriah Y: NF-kappaB functions as a tumour promoter in
inflammation-associated cancer. Nature. 431:461–466. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ketloy C, Engering A, Srichairatanakul U,
Limsalakpetch A, Yongvanitchit K, Pichyangkul S and Ruxrungtham K:
Expression and function of Toll-like receptors on dendritic cells
and other antigen presenting cells from non-human primates. Vet
Immunol Immunopathol. 125:18–30. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ochi A, Graffeo CS, Zambirinis CP, Rehman
A, Hackman M, Fallon N, Barilla RM, Henning JR, Jamal M, Rao R, et
al: Toll-like receptor 7 regulates pancreatic carcinogenesis in
mice and humans. J Clin Invest. 122:4118–4129. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cherfils-Vicini J, Platonova S, Gillard M,
Laurans L, Validire P, Caliandro R, Magdeleinat P, Mami-Chouaib F,
Dieu-Nosjean MC, Fridman WH, et al: Triggering of TLR7 and TLR8
expressed by human lung cancer cells induces cell survival and
chemoresistance. J Clin Invest. 120:1285–1297. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Janeway CA Jr: Approaching the asymptote?
Evolution and revolution in immunology. Cold Spring Harb Symp Quant
Biol. 54:1–13. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rubartelli A and Lotze MT: Inside,
outside, upside down: Damage-associated molecular-pattern molecules
(DAMPs) and redox. Trends Immunol. 28:429–436. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Grimm M, Kim M, Rosenwald A, Heemann U,
Germer CT, Waaga-Gasser AM and Gasser M: Toll-like receptor (TLR) 7
and TLR8 expression on CD133+ cells in colorectal cancer
points to a specific role for inflammation-induced TLRs in
tumourigenesis and tumour progression. Eur J Cancer. 46:2849–2857.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bowie A and O'Neill LA: The interleukin-1
receptor/Toll-like receptor superfamily: Signal generators for
pro-inflammatory interleukins and microbial products. J Leukoc
Biol. 67:508–514. 2000.PubMed/NCBI
|
|
15
|
Harris RE: Cyclooxygenase-2 (cox-2) and
the inflammogenesis of cancer. Subcell Biochem. 42:93–126. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bong AB, Bonnekoh B, Franke I, Schön M,
Ulrich J and Gollnick H: Imiquimod, a topical immune response
modifier, in the treatment of cutaneous metastases of malignant
melanoma. Dermatology. 205:135–138. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dunne A, Marshall NA and Mills KH: TLR
based therapeutics. Curr Opin Pharmacol. 11:404–411. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Conroy T, Desseigne F, Ychou M, Bouché O,
Guimbaud R, Bécouarn Y, Adenis A, Raoul JL, Gourgou-Bourgade S, de
la Fouchardière C, et al; Groupe Tumeurs Digestives of Unicancer;
PRODIGE Intergroup. FOLFIRINOX versus gemcitabine for metastatic
pancreatic cancer. N Engl J Med. 364:1817–1825. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chang YJ, Wu MS, Lin JT and Chen CC:
Helicobacter pylori-induced invasion and angiogenesis of gastric
cells is mediated by cyclooxygenase-2 induction through TLR2/TLR9
and promoter regulation. J Immunol. 175:8242–8252. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
de Moraes E, Dar NA, de Moura Gallo CV and
Hainaut P: Crosstalks between cyclooxygenase-2 and tumor suppressor
protein p53: Balancing life and death during inflammatory stress
and carcinogenesis. Int J Cancer. 121:929–937. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dvorak HF: Angiogenesis: Update 2005. J
Thromb Haemost. 3:1835–1842. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yip-Schneider MT, Barnard DS, Billings SD,
Cheng L, Heilman DK, Lin A, Marshall SJ, Crowell PL, Marshall MS
and Sweeney CJ: Cyclooxygenase-2 expression in human pancreatic
adenocarcinomas. Carcinogenesis. 21:139–146. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hattermann K, Picard S, Borgeat M, Leclerc
P, Pouliot M and Borgeat P: The Toll-like receptor 7/8-ligand
resiquimod (R-848) primes human neutrophils for leukotriene B4,
prostaglandin E2 and platelet-activating factor biosynthesis. FASEB
J. 21:1575–1585. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Meteoglu I, Erdogdu IH, Meydan N, Erkus M
and Barutca S: NF-KappaB expression correlates with apoptosis and
angiogenesis in clear cell renal cell carcinoma tissues. J Exp Clin
Cancer Res. 27:532008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Burris HA III, Moore MJ, Andersen J, Green
MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo
AM, Tarassoff P, et al: Improvements in survival and clinical
benefit with gemcitabine as first-line therapy for patients with
advanced pancreas cancer: A randomized trial. J Clin Oncol.
15:2403–2413. 1997.PubMed/NCBI
|
|
26
|
Wang Z, Li Y, Ahmad A, Banerjee S, Azmi
AS, Kong D and Sarkar FH: Pancreatic cancer: Understanding and
overcoming chemoresistance. Nat Rev Gastroenterol Hepatol. 8:27–33.
2011. View Article : Google Scholar
|
|
27
|
Güngör C, Zander H, Effenberger KE,
Vashist YK, Kalinina T, Izbicki JR, Yekebas E and Bockhorn M: Notch
signaling activated by replication stress-induced expression of
midkine drives epithelial-mesenchymal transition and
chemoresistance in pancreatic cancer. Cancer Res. 71:5009–5019.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hu X, Chung AY, Wu I, Foldi J, Chen J, Ji
JD, Tateya T, Kang YJ, Han J, Gessler M, et al: Integrated
regulation of Toll-like receptor responses by Notch and
interferon-gamma pathways. Immunity. 29:691–703. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hemmi H, Noike M, Nakayama T and Nishino
T: Change of product specificity of hexaprenyl diphosphate synthase
from Sulfolobus solfataricus by introducing mimetic mutations.
Biochem Biophys Res Commun. 297:1096–1101. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jurk M, Heil F, Vollmer J, Schetter C,
Krieg AM, Wagner H, Lipford G and Bauer S: Human TLR7 or TLR8
independently confer responsiveness to the antiviral compound
R-848. Nat Immunol. 3:4992002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Scheel B, Aulwurm S, Probst J, Stitz L,
Hoerr I, Rammensee HG, Weller M and Pascolo S: Therapeutic
anti-tumor immunity triggered by injections of immunostimulating
single-stranded RNA. Eur J Immunol. 36:2807–2816. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sauder DN, Smith MH, Senta-McMillian T,
Soria I and Meng TC: Randomized, single-blind, placebo-controlled
study of topical application of the immune response modulator
resiquimod in healthy adults. Antimicrob Agents Chemother.
47:3846–3852. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chiron D, Pellat-Deceunynck C, Amiot M,
Bataille R and Jego G: TLR3 ligand induces NF-{kappa}B activation
and various fates of multiple myeloma cells depending on
IFN-{alpha} production. J Immunol. 182:4471–4478. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hsu RY, Chan CH, Spicer JD, Rousseau MC,
Giannias B, Rousseau S and Ferri LE: LPS-induced TLR4 signaling in
human colorectal cancer cells increases beta1 integrin-mediated
cell adhesion and liver metastasis. Cancer Res. 71:1989–1998. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Thuringer D, Hammann A, Benikhlef N,
Fourmaux E, Bouchot A, Wettstein G, Solary E and Garrido C:
Transactivation of the epidermal growth factor receptor by heat
shock protein 90 via Toll-like receptor 4 contributes to the
migration of glioblastoma cells. J Biol Chem. 286:3418–3428. 2011.
View Article : Google Scholar :
|
